We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Corgenix Announces Initial Phase Completion of Clinical Trial of Rapid Test for Lassa Fever

News   Apr 23, 2013

 
Corgenix Announces Initial Phase Completion of Clinical Trial of Rapid Test for Lassa Fever
 
 
 

RELATED ARTICLES

75,000-molecule Screen Reveals Amyloid-reducing Compound

News

Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer’s disease (AD).

READ MORE

Compound Could Help Treat Ovarian Cancer

News

Scientists from the University of Sheffield have discovered a compound that could be more effective in treating certain cancers than standard chemotherapy.

READ MORE

A Solution for Pollen Allergies?

News

Birch pollen allergic rhinitis is the most common chronic disorder in the Northern part of the globe, and it attributes to significant morbidity and economic burden. According to a new study, pollen allergen immunotherapy has favorable effects on the molecular events and microbiome profile in the nasal membrane.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE